Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 5 of 27.
- R40.2443Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission
- R40.2444Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission
- R40.2ANontraumatic coma due to underlying condition
- R41.83Borderline intellectual functioning
- R45.850Homicidal ideations
- R46.81Obsessive-compulsive behavior
- R46.89Other symptoms and signs involving appearance and behavior
- R65.10Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction
- R65.11Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction
- R65.20Severe sepsis without septic shock
- R65.21Severe sepsis with septic shock
- S06.A0XATraumatic brain compression without herniation, initial encounter
- S06.A0XDTraumatic brain compression without herniation, subsequent encounter
- S06.A0XSTraumatic brain compression without herniation, sequela
- S06.A1XATraumatic brain compression with herniation, initial encounter
- S06.A1XDTraumatic brain compression with herniation, subsequent encounter
- S06.A1XSTraumatic brain compression with herniation, sequela
- T36.0X5AAdverse effect of penicillins, initial encounter
- T36.0X5DAdverse effect of penicillins, subsequent encounter
- T36.0X5SAdverse effect of penicillins, sequela
- T36.0X6AUnderdosing of penicillins, initial encounter
- T36.0X6DUnderdosing of penicillins, subsequent encounter
- T36.0X6SUnderdosing of penicillins, sequela
- T36.1X5AAdverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
- T36.1X5DAdverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
- T36.1X5SAdverse effect of cephalosporins and other beta-lactam antibiotics, sequela
- T36.1X6AUnderdosing of cephalosporins and other beta-lactam antibiotics, initial encounter
- T36.1X6DUnderdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounter
- T36.1X6SUnderdosing of cephalosporins and other beta-lactam antibiotics, sequela
- T36.2X5AAdverse effect of chloramphenicol group, initial encounter
- T36.2X5DAdverse effect of chloramphenicol group, subsequent encounter
- T36.2X5SAdverse effect of chloramphenicol group, sequela
- T36.2X6AUnderdosing of chloramphenicol group, initial encounter
- T36.2X6DUnderdosing of chloramphenicol group, subsequent encounter
- T36.2X6SUnderdosing of chloramphenicol group, sequela
- T36.3X5AAdverse effect of macrolides, initial encounter
- T36.3X5DAdverse effect of macrolides, subsequent encounter
- T36.3X5SAdverse effect of macrolides, sequela
- T36.3X6AUnderdosing of macrolides, initial encounter
- T36.3X6DUnderdosing of macrolides, subsequent encounter
- T36.3X6SUnderdosing of macrolides, sequela
- T36.4X5AAdverse effect of tetracyclines, initial encounter
- T36.4X5DAdverse effect of tetracyclines, subsequent encounter
- T36.4X5SAdverse effect of tetracyclines, sequela
- T36.4X6AUnderdosing of tetracyclines, initial encounter
- T36.4X6DUnderdosing of tetracyclines, subsequent encounter
- T36.4X6SUnderdosing of tetracyclines, sequela
- T36.5X5AAdverse effect of aminoglycosides, initial encounter
- T36.5X5DAdverse effect of aminoglycosides, subsequent encounter
- T36.5X5SAdverse effect of aminoglycosides, sequela
- T36.5X6AUnderdosing of aminoglycosides, initial encounter
- T36.5X6DUnderdosing of aminoglycosides, subsequent encounter
- T36.5X6SUnderdosing of aminoglycosides, sequela
- T36.6X5AAdverse effect of rifampicins, initial encounter
- T36.6X5DAdverse effect of rifampicins, subsequent encounter
- T36.6X5SAdverse effect of rifampicins, sequela
- T36.6X6AUnderdosing of rifampicins, initial encounter
- T36.6X6DUnderdosing of rifampicins, subsequent encounter
- T36.6X6SUnderdosing of rifampicins, sequela
- T36.7X5AAdverse effect of antifungal antibiotics, systemically used, initial encounter
- T36.7X5DAdverse effect of antifungal antibiotics, systemically used, subsequent encounter
- T36.7X5SAdverse effect of antifungal antibiotics, systemically used, sequela
- T36.7X6AUnderdosing of antifungal antibiotics, systemically used, initial encounter
- T36.7X6DUnderdosing of antifungal antibiotics, systemically used, subsequent encounter
- T36.7X6SUnderdosing of antifungal antibiotics, systemically used, sequela
- T36.8X5AAdverse effect of other systemic antibiotics, initial encounter
- T36.8X5DAdverse effect of other systemic antibiotics, subsequent encounter
- T36.8X5SAdverse effect of other systemic antibiotics, sequela
- T36.8X6AUnderdosing of other systemic antibiotics, initial encounter
- T36.8X6DUnderdosing of other systemic antibiotics, subsequent encounter
- T36.8X6SUnderdosing of other systemic antibiotics, sequela
- T36.95XAAdverse effect of unspecified systemic antibiotic, initial encounter
- T36.95XDAdverse effect of unspecified systemic antibiotic, subsequent encounter
- T36.95XSAdverse effect of unspecified systemic antibiotic, sequela
- T36.96XAUnderdosing of unspecified systemic antibiotic, initial encounter
- T36.96XDUnderdosing of unspecified systemic antibiotic, subsequent encounter
- T36.96XSUnderdosing of unspecified systemic antibiotic, sequela
- T36.AX5AAdverse effect of fluoroquinolone antibiotics, initial encounter
- T36.AX5DAdverse effect of fluoroquinolone antibiotics, subsequent encounter
- T36.AX5SAdverse effect of fluoroquinolone antibiotics, sequela
- T36.AX6AUnderdosing of fluoroquinolone antibiotics, initial encounter
- T36.AX6DUnderdosing of fluoroquinolone antibiotics, subsequent encounter
- T36.AX6SUnderdosing of fluoroquinolone antibiotics, sequela
- T37.0X5AAdverse effect of sulfonamides, initial encounter
- T37.0X5DAdverse effect of sulfonamides, subsequent encounter
- T37.0X5SAdverse effect of sulfonamides, sequela
- T37.0X6AUnderdosing of sulfonamides, initial encounter
- T37.0X6DUnderdosing of sulfonamides, subsequent encounter
- T37.0X6SUnderdosing of sulfonamides, sequela
- T37.1X5AAdverse effect of antimycobacterial drugs, initial encounter
- T37.1X5DAdverse effect of antimycobacterial drugs, subsequent encounter
- T37.1X5SAdverse effect of antimycobacterial drugs, sequela
- T37.1X6AUnderdosing of antimycobacterial drugs, initial encounter
- T37.1X6DUnderdosing of antimycobacterial drugs, subsequent encounter
- T37.1X6SUnderdosing of antimycobacterial drugs, sequela
- T37.2X5AAdverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
- T37.2X5DAdverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
- T37.2X5SAdverse effect of antimalarials and drugs acting on other blood protozoa, sequela
- T37.2X6AUnderdosing of antimalarials and drugs acting on other blood protozoa, initial encounter
- T37.2X6DUnderdosing of antimalarials and drugs acting on other blood protozoa, subsequent encounter